Benzinga | Mar 4, 2021 04:03PM EST

DermTech Q4 EPS $(0.48) Beats $(0.55) Estimate, Sales $2.10M Beat $1.78M Estimate

DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.55) by 12.73 percent. This is a 500 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $2.10 million which beat the analyst consensus estimate of $1.78 million by 17.98 percent. This is a 32.16 percent increase over sales of $1.59 million the same period last year.